STAT3 and pancreatic neoplasm: STAT3 can be considered as the intersection of multiple oncogenic signaling pathways, activated in immune cells and cancer cells in pancreatic cancer TME, promoting the production of immunosuppressive factors that alter gene expression programs and suppress anti-tumor immune responses.